HECT‐Type Ubiquitin E3 Ligase ITCH Interacts With Thioredoxin‐Interacting Protein and Ameliorates Reactive Oxygen Species–Induced Cardiotoxicity

  • Yoichiro Otaki
    Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan
  • Hiroki Takahashi
    Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan
  • Tetsu Watanabe
    Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan
  • Akira Funayama
    Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan
  • Shunsuke Netsu
    Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan
  • Yuki Honda
    Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan
  • Taro Narumi
    Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan
  • Shinpei Kadowaki
    Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan
  • Hiromasa Hasegawa
    Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan
  • Shintaro Honda
    Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan
  • Takanori Arimoto
    Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan
  • Tetsuro Shishido
    Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan
  • Takuya Miyamoto
    Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan
  • Hideaki Kamata
    Laboratory of Biomedical Chemistry, Department of Molecular Medical Science, Graduate School of Medicine, University of Hiroshima, Japan
  • Osamu Nakajima
    Research Laboratory for Molecular Genetics, Yamagata University School of Medicine, Yamagata, Japan
  • Isao Kubota
    Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan

書誌事項

公開日
2016-01-13
資源種別
journal article
DOI
  • 10.1161/jaha.115.002485
公開者
Ovid Technologies (Wolters Kluwer Health)

説明

<jats:sec xml:lang="en"> <jats:title>Background</jats:title> <jats:p xml:lang="en"> The <jats:styled-content style="fixed-case">homologous to the E6‐AP carboxyl terminus (HECT)</jats:styled-content> –type ubiquitin E3 ligase <jats:styled-content style="fixed-case">ITCH</jats:styled-content> is an enzyme that plays a pivotal role in posttranslational modification by ubiquitin proteasomal protein degradation. Thioredoxin‐interacting protein ( <jats:styled-content style="fixed-case">TXNIP</jats:styled-content> ) is a negative regulator of the thioredoxin system and an endogenous reactive oxygen species scavenger. In the present study, we focused on the functional role of ubiquitin E3 ligase <jats:styled-content style="fixed-case">ITCH</jats:styled-content> and its interaction with <jats:styled-content style="fixed-case">TXNIP</jats:styled-content> to elucidate the mechanism of cardiotoxicity induced by <jats:styled-content style="fixed-case">reactive oxygen species</jats:styled-content> , such as doxorubicin and hydrogen peroxide. </jats:p> </jats:sec> <jats:sec xml:lang="en"> <jats:title>Methods and Results</jats:title> <jats:p xml:lang="en"> Protein interaction between <jats:styled-content style="fixed-case">TXNIP</jats:styled-content> and <jats:styled-content style="fixed-case">ITCH</jats:styled-content> in cardiomyocyte was confirmed by immunoprecipitation assays. Overexpression of <jats:styled-content style="fixed-case">ITCH</jats:styled-content> increased proteasomal <jats:styled-content style="fixed-case">TXNIP</jats:styled-content> degradation and augmented thioredoxin activity, leading to inhibition of <jats:styled-content style="fixed-case">reactive oxygen species</jats:styled-content> generation, p38 <jats:styled-content style="fixed-case">MAPK</jats:styled-content> , p53, and subsequent intrinsic pathway cardiomyocyte apoptosis in <jats:styled-content style="fixed-case">reactive oxygen species</jats:styled-content> –induced cardiotoxicity. Conversely, knockdown of <jats:styled-content style="fixed-case">ITCH</jats:styled-content> using small interfering <jats:styled-content style="fixed-case">RNA</jats:styled-content> inhibited <jats:styled-content style="fixed-case">TXNIP</jats:styled-content> degradation and resulted in a subsequent increase in cardiomyocyte apoptosis. Next, we generated a transgenic mouse with cardiac‐specific overexpression of <jats:styled-content style="fixed-case">ITCH</jats:styled-content> , called the <jats:styled-content style="fixed-case">ITCH</jats:styled-content> ‐Tg mouse. The expression level of <jats:styled-content style="fixed-case">TXNIP</jats:styled-content> in the myocardium in <jats:styled-content style="fixed-case">ITCH</jats:styled-content> ‐Tg mice was significantly lower than WT littermates. In <jats:styled-content style="fixed-case">ITCH</jats:styled-content> ‐Tg mice, cardiac dysfunction and remodeling were restored compared with WT littermates after doxorubicin injection and myocardial infarction surgery. Kaplan–Meier analysis revealed that <jats:styled-content style="fixed-case">ITCH</jats:styled-content> ‐Tg mice had a higher survival rate than WT littermates after doxorubicin injection and myocardial infarction surgery. </jats:p> </jats:sec> <jats:sec xml:lang="en"> <jats:title>Conclusion</jats:title> <jats:p xml:lang="en"> We demonstrated, for the first time, that <jats:styled-content style="fixed-case">ITCH</jats:styled-content> targets <jats:styled-content style="fixed-case">TXNIP</jats:styled-content> for ubiquitin‐proteasome degradation in cardiomyocytes and ameliorates <jats:styled-content style="fixed-case">reactive oxygen species</jats:styled-content> –induced cardiotoxicity through the thioredoxin system. </jats:p> </jats:sec>

収録刊行物

被引用文献 (5)*注記

もっと見る

参考文献 (45)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ